Kedrion Biopharma
Emily Fowler is a Senior Project Scientist with extensive experience in the biopharmaceutical sector, having worked at Kedrion Biopharma and Bio Products Laboratory Limited. Previously, Emily held the role of Formulation Research Scientist at Intract Pharma Ltd and served as a Senior Scientist at Pharmidex. Emily's academic background includes a PhD Research Scientist position at The University of Edinburgh, where educational qualifications were attained, including a Bachelor's Degree in Molecular Cell Biology from the University of York. Emily's expertise encompasses areas in molecular biology and project management within the pharmaceutical industry.
This person is not in the org chart
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.